Prognostic Role of Zinc Finger Homeobox 4 in Ovarian Serous Cystadenocarcinoma.

The zinc finger homeobox 4 (ZFHX4) protein is a crucial molecular regulator of tumor-initiating stem cell-like functions. This study aimed to determine the role of ZFHX4 in the progression of ovarian serous cystadenocarcinoma (OSC). Differential gene expression among low-stage (stages I and II), high-stage (stages III and IV), low-grade (grades I and II), and high-grade (grades III and IV) OSC patients was identified using four independent cohorts from the Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO). We compared expression as a prognostic factor using Kaplan-Meier survival curves, multivariate analysis, the time-dependent area under the curve (AUC) of Uno's C-index, and the AUC of the receiver operating characteristics at 4 years post diagnosis. gene expression in high-stage tumors is significantly higher than in low-stage tumors (TCGA,  = 0.007; GSE9891,  = 0.001). A Kaplan-Meier analysis revealed that elevated expression of was associated with a poor prognosis in OSC patients for all cohorts, regardless of stage and grade (TCGA,  = 1e-04; GSE9891,  = 0.0044; GSE13876,  = 0.00078; GSE26712,  = 0.039). Analysis of C-indices and the area under the receiver operating characteristic curve further supported this result (C-index: TCGA, 0.599; GSE9891, 0.642; GSE13876, 0.585; GSE26712, 0.597). Moreover, univariate and multivariate Cox hazards analyses confirmed the prognostic significance of levels. Collectively, these findings suggest that ZFHX4 is a prognostic factor for OSC.